Healthcare Use during the Last Six Months of Life in Patients with Advanced Breast Cancer

Renée Schmitz(The Netherlands Cancer Institute), Maaike de Boer(Maastricht University), Khava I. E. Ibragimova(Maastricht University), D Tilli(Maastricht University), Sandra M. E. Geurts(Maastricht University), Vivianne C. G. Tjan‐Heijnen(Maastricht University Medical Centre)

Cancers

October 20, 2021

10.3390/cancers13215271

Cited by 7

Related Papers

Pervasive chromosomal instability and karyotype order in tumour evolution

|Nature|2020|401

Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study

|BMJ|2023|44

Active surveillance versus treatment in low-risk DCIS: Women’s preferences in the LORD-trial

|European Journal of Cancer|2023|39

Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer

|Cancer Treatment Reviews|2022|35

Patient-Reported Outcome Measurement Compared with Professional Judgment of Cosmetic Results after Breast-Conserving Therapy

|Current Oncology|2018|20